[ANNOUNCEMENT ON KEY OPERATING DATA The relevant key operating data was calculated based on the internal statistics of the Group, which may differ from the data disclosed in the relative periodic reports. Investors are hereby reminded of the risks which may result from inappropriate reliance upon or ]
[ANNOUNCEMENT ON KEY OPERATING DATA The relevant key operating data was calculated based on the internal statistics of the Group, which may differ from the data disclosed in the relative periodic reports. Investors are hereby reminded of the risks which may result from inappropriate reliance upon or ]
[NetEase, Inc. Building No. 7, West Zone, Zhongguancun Software Park (Phase II), No. 10 Xibeiwang East Road, Haidian District Beijing, Peoples Republic of China 100193 NOTICE OF 2019 ANNUAL GENERAL MEETING OF SHAREHOLDERS TO BE HELD ON SEPTEMBER 13 Important Notice Regarding the Availability of Prox]
[SECURITIES PURCHASE AGREEMENT Agreement Company Purchaser Purchasers This SECURITIES PURCHASE AGREEMENT (the “ RECITALS WHEREAS, the Company is offering certain shares of its common stock, par value $0.001 per share, (the “Common Stock”) at price of $12.00 per share to the Purchasers; NOW, THEREFORE]
[NetEase, Inc. Building No. 7, West Zone, Zhongguancun Software Park (Phase II), No. 10 Xibeiwang East Road, Haidian District Beijing, Peoples Republic of China 100193 NOTICE OF 2019 ANNUAL GENERAL MEETING OF SHAREHOLDERS TO BE HELD ON SEPTEMBER 13 Important Notice Regarding the Availability of Prox]
[SECURITIES PURCHASE AGREEMENT Agreement Company Purchaser Purchasers This SECURITIES PURCHASE AGREEMENT (the “ RECITALS WHEREAS, the Company is offering certain shares of its common stock, par value $0.001 per share, (the “Common Stock”) at price of $12.00 per share to the Purchasers; NOW, THEREFORE]
[Sinovac Reports Unaudited Second Quarter 2019 Financial Results BEIJING, China, August 15, 2019 /Business Wire/ -- Sinovac Biotech Ltd. (NASDAQ: SVA) (“Sinovac” or the “Company”), a leading provider of biopharmaceutical products in China, announced today its unaudited financial results for the secon]
[Sinovac Reports Unaudited Second Quarter 2019 Financial Results BEIJING, China, August 15, 2019 /Business Wire/ -- Sinovac Biotech Ltd. (NASDAQ: SVA) (“Sinovac” or the “Company”), a leading provider of biopharmaceutical products in China, announced today its unaudited financial results for the secon]
[Xinyuan Real Estate Co., Ltd. Announces Second Quarter 2019 Financial Results BEIJING, China, August 16, 2019 Highlights · First half contract sales of 2019 increased 3.4% to RMB6,676.3 million from RMB6,457.0 million in the first half of 2018. · Contract sales decreased 20.0% to US$507.4 million fr]
[Xinyuan Real Estate Co., Ltd. Announces Second Quarter 2019 Financial Results BEIJING, China, August 16, 2019 Highlights · First half contract sales of 2019 increased 3.4% to RMB6,676.3 million from RMB6,457.0 million in the first half of 2018. · Contract sales decreased 20.0% to US$507.4 million fr]
